Uveitis Unknown Status Phase 1 Trials for Adalimumab (DB00051)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Unknown Status1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00855608Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot StudyTreatment